Dapagliflozin + metformin
- 1 lab in 2 countries
- Animals1
Outcomes
1Liver fibrosis
downin rats1
1 study
Liver fibrosis
downin rats1
Dapagliflozin + metformin decreases liver fibrosis in rats.
“Notably, combination therapy yielded synergistic anti-fibrotic effects.”
Animalsin TAA-induced liver fibrosislivermales
Advanced pharmaceutical bulletin22 Dec 2025
Latest
10 in 12 monthsBMC Endocrine Disorders
Effects of SGLT-2 inhibitors on thyroid-stimulating hormone and systemic immune-inflammation index in type 2 diabetes: a retrospective study
Cross-sectional study of 330 peopleSGLT2 inhibitors
Frontiers in Endocrinology
Adverse event reporting signals for SGLT-2 inhibitor-metformin combination therapy: a disproportionality analysis of the FAERS database
Computational studySGLT2 inhibitors
Advanced Pharmaceutical Bulletin
Dual Modulation of Senescence and Immune Checkpoints by Metformin and Dapagliflozin Attenuates Liver Fibrosis in a Thioacetamide-Induced Rat Model
Experiments in ratsDapagliflozin
ADA Scientific Sessions 2026 Abstract
Orforglipron vs. Dapagliflozin in Type 2 Diabetes Inadequately Controlled with Metformin
Randomised trial in 962 peopleOrforglipron
ADA Scientific Sessions 2026 Abstract
Long-Term Impact of Early Oral Antidiabetic Therapy on Insulin Secretion Phases in Individuals with Prediabetes (PreDM): Insights from Hyperglycemic Clamp Studies
Non-randomised trial in 60 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Real-World Effectiveness and Safety of Dapagliflozin/Glimepiride/Metformin Fixed-Dose Combinations (FDC) in Indian Adults with Type 2 Diabetes Mellitus (T2DM): Insights from BENEFACTOR Study
Cohort study of 3,770 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Effects of Tirzepatide in Obese Adults with Type 1 Diabetes on Hybrid Closed-Loop Continuous Subcutaneous Insulin Infusion: A 12-Month Observational Study
Cohort study of 26 peopleTirzepatide